quant Mutual FundEquity Scheme - Mid Cap Fund13.7 years
The scheme aims at providing long term capital appreciation and generating income with a diversified portfolio of Mid Cap companies.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY MIDCAP 150 TRI. Capture ratios use common month-end observations through 16 Sept 2026.
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
29 Jan 2020 – 3 Aug 2020
Trough 23 Mar 2020 · recovered in 133 days
-33.4%
15 Jul 2024 – open
Trough 4 Mar 2025 · not recovered
-26.0%
31 Aug 2018 – 29 Jan 2020
Trough 22 Aug 2019 · recovered in 160 days
-19.5%
11 Apr 2022 – 5 Sept 2022
Trough 20 Jun 2022 · recovered in 77 days
-18.5%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
18
Vs category
35
Consistency
52
Risk-adjusted
62
Drawdown
16
Mean
37
31 Aug 2026 · 43 holdings · top 10 are 66.5%.
Aurobindo Pharma Ltd
Healthcare
10.4%
Tata Communications Ltd
Technology
8.4%
Lloyds Metals and Energy Ltd
Materials
8.2%
Repo
Unspecified
7.8%
IRB Infrastructure Developers Ltd
Industrials
6.0%
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Engine status
Monitor
Recent evidence
Why this status
Supporting reads
Same-category peers with enough history to inspect beside this fund.
Baroda BNP Paribas Mutual Fund
Franklin Templeton Mutual Fund
Caveat: Deeper drawdown
ITI Mutual Fund
Caveat: Higher volatility
LIC Mutual Fund
Caveat: Higher volatility
Union Mutual Fund
Caveat: Higher volatility
quant Mutual FundEquity Scheme - Mid Cap Fund13.7 years
The scheme aims at providing long term capital appreciation and generating income with a diversified portfolio of Mid Cap companies.
NAV
15 Sept 2026 · +2.5% over 1Y
242.7838
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY MIDCAP 150 TRI. Capture ratios use common month-end observations through 16 Sept 2026.
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
15 Sept 2026
-13.6%
29 Jan 2020 – 3 Aug 2020
Trough 23 Mar 2020 · recovered in 133 days
-33.4%
15 Jul 2024 – open
Trough 4 Mar 2025 · not recovered
-26.0%
31 Aug 2018 – 29 Jan 2020
Trough 22 Aug 2019 · recovered in 160 days
-19.5%
11 Apr 2022 – 5 Sept 2022
Trough 20 Jun 2022 · recovered in 77 days
-18.5%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
18
Vs category
35
Consistency
52
Risk-adjusted
62
Drawdown
16
Mean
37
31 Aug 2026 · 43 holdings · top 10 are 66.5%.
Aurobindo Pharma Ltd
Healthcare
10.4%
Tata Communications Ltd
Technology
8.4%
Lloyds Metals and Energy Ltd
Materials
8.2%
Repo
Unspecified
7.8%
IRB Infrastructure Developers Ltd
Industrials
6.0%
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Engine status
Monitor
Recent evidence
Why this status
Supporting reads